Orthofix Medical Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
Orthofix Medical Inc. (OFIX) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $15.81 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2026-02-24
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $15.81M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $17.22M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $15.43M; Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits as first filed $14.86M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $8.79M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits as first filed |
|---|---|---|
| 2025-12-31 | $15.81M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $17.22M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $15.43M 10-K · filed 2025-02-25 | $14.86M 10-K · filed 2024-03-05 |
| 2022-12-31 | $8.79M 10-K · filed 2024-03-05 | |
| 2021-12-31 | $7.78M 10-K · filed 2023-03-06 | |
| 2020-12-31 | $8.73M 10-K · filed 2022-02-25 | |
| 2019-12-31 | $9.22M 10-K · filed 2021-02-26 | |
| 2018-12-31 | $8.32M 10-K · filed 2020-02-24 | |
| 2017-12-31 | $4.05M 10-K · filed 2019-02-25 | |
| 2016-12-31 | $6.75M 10-K · filed 2018-02-26 | |
| 2015-12-31 | $2.96M 10-K · filed 2017-02-27 | |
| 2014-12-31 | $5.00M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $3.94M 10-K · filed 2015-04-29 | $3.88M 10-K · filed 2014-03-31 |
| 2012-12-31 | $3.79M 10-K/A · filed 2015-03-31 | $3.60M 10-K · filed 2013-03-01 |
| 2011-12-31 | $4.44M 10-K/A · filed 2014-03-24 | $6.83M 10-K · filed 2012-02-29 |
| 2010-12-31 | $15.48M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |